Learn / ARVN
NASDAQ: ARVN
Arvinas (ARVN) stock, explained like you're 5
Arvinas trades on the Nasdaq under the ticker ARVN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 500 million dollars.
- Ticker
- ARVN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 500 million dollars
Is Arvinas a small, medium or large cap company?
No. Arvinas is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 500 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Arvinas makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ARVN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Arvinas, Inc. (ARVN) stock price, news, quote and history (Yahoo Finance UK)
- ARVN Stock Drops On CEO Exit Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff (Stocktwits)
- Reasons Why Investors Should Consider Betting on Arvinas Stock (Yahoo Finance)
- ARVN Forecast Price Target Prediction for 2027 (TradingView)
- Arvinas, Inc. (NASDAQ:ARVN) Stock Has Average Price Target of $14.55 (MarketBeat)
Follow ARVN in your daily brief
Each trading day at 5 PM ET we post what happened to Arvinas and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ARVN
Questions about Arvinas stock
What does Arvinas do?
Arvinas trades on the Nasdaq under the ticker ARVN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 500 million dollars.
What is the ticker symbol for Arvinas?
Arvinas trades under the ticker ARVN on the Nasdaq.
What is Arvinas's market cap?
Arvinas is a small cap stock with a market cap of about 500 million dollars.
How does Arvinas make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ARVN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ARVN stock every day?
Add ARVN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.